What are the treatment options for neuropathy after reverse total shoulder replacement surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Neuropathy After Reverse Total Shoulder Arthroplasty

The first-line treatment for neuropathy after reverse total shoulder arthroplasty should include gabapentin or pregabalin, which are effective for managing neuropathic pain with good evidence for efficacy and tolerability. 1

Medication Options

First-Line Treatments

  • Gabapentin and pregabalin are recommended as first-line treatments for neuropathic pain, acting by binding to the α-2-δ subunit of voltage-gated calcium channels 1
  • Start with low doses and titrate gradually: gabapentin typically titrated to 2400 mg per day in divided doses 1
  • Pregabalin can be started at 75 mg twice daily and titrated as needed up to 300-600 mg/day 1
  • Dose adjustments are necessary in patients with renal impairment 1

Alternative First-Line Options

  • Tricyclic antidepressants (TCAs) like nortriptyline and desipramine are effective first-line alternatives 1
  • Start TCAs at low doses (10 mg/day) and titrate slowly to a maximum of 75 mg/day, especially in older adults 1
  • Obtain a screening ECG for patients over 40 years before starting TCAs due to potential cardiac risks 1
  • Selective serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine (60-120 mg/day) and venlafaxine (150-225 mg/day) have fewer anticholinergic effects than TCAs 1

Topical Treatments

  • Consider 5% lidocaine patches for localized peripheral neuropathic pain, particularly with allodynia 1
  • High-concentration capsaicin patches may be beneficial for localized neuropathic pain 1

Treatment Algorithm

  1. Assess the type and location of neuropathy:

    • Determine which nerve is affected - axillary nerve (41.2%) and radial nerve (15%) are most commonly involved after RTSA 2
    • Evaluate for symptoms such as numbness, tingling, hyperalgesia, and/or allodynia in the distribution of the affected nerve 3
  2. First-line treatment:

    • For diffuse neuropathic pain: Start with gabapentin or pregabalin 1
    • For localized peripheral neuropathic pain: Consider topical lidocaine or capsaicin 1
  3. If partial response after adequate trial:

    • Add another first-line agent from a different class (e.g., add duloxetine to gabapentin) 1
  4. If inadequate response to first-line agents:

    • Consider second-line treatments such as tramadol (starting at 50 mg once or twice daily, maximum 400 mg/day) 1
    • Use lower doses in older adults and those with renal/hepatic dysfunction 1
  5. For refractory cases:

    • Consider referral to pain specialist or multidisciplinary pain center 1
    • Peripheral nerve stimulation may be an option for persistent pain - a case report showed improvement in shoulder function and pain reduction with axillary nerve stimulation 4

Special Considerations

  • Most neurologic deficits after RTSA are temporary and resolve with conservative management - studies show complete recovery in most patients within an average of 7.4 months 2
  • Neurologic deficit after RTSA occurs in approximately 19% of patients and is significantly correlated with humeral distalization after surgery 2
  • Distal peripheral neuropathy (DPN) is an under-reported complication after shoulder surgery, with 12.3% of reverse shoulder arthroplasty patients developing DPN 5
  • The most common form of DPN after RTSA is cubital tunnel syndrome 5
  • Conservative treatment resolves symptoms in approximately 42.86% of RTSA patients with DPN, but 14.3% may require surgical decompression 5
  • Surgical decompression is highly effective for refractory cases, with 100% of patients achieving complete resolution of symptoms after decompression 5

Monitoring and Follow-up

  • Regular assessment of pain intensity, functional improvement, and adverse effects 1
  • If substantial pain relief (≥50% reduction) is achieved with tolerable side effects, continue treatment 1
  • For patients with ulnar nerve neuropathy after RTSA, electrodiagnostic and ultrasound studies should be performed to confirm and assess the site and severity of the injury 3
  • Be aware that surgical intervention for ulnar nerve neuropathy following RTSA may have limited success, with complete symptom resolution in only a minority of patients 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.